Happy humpday mi amors!

As the oil sector rallied yesterday on worries over Iran and Greece, Exit only (Pink: EXTO) aka Bayport Corporation a well known stinky pinky holdings group with a strong focus on crude also benefited as the stock went on a tear from .006 to .009 before settling back down to close right at a former resistance and now tentative support level of .0075.

We covered EXTO back in Dec. at an all you could eat buffet of shares at an avg. price of .0055, so that’s a gain upwards of 80% in 2 months! So if you are one of the patient roaches that sat on a few shares of EXTO (and I know there’s quite a few of you lurking around) it’s almost like found money! Cha-ching!

EXTO coverage from Dec. http://www.stockroach.com/senoritas-humpday-special-is-exit-only-inc-pink-exto/

Does your Senorita think that the rally at EXTO can continue? Well, the charts say, “Yes it can.” and with buys outnumbering sells by almost 5:1 during yesterday’s trading, the chart is getting mucho caliente. There’s the beautiful MACD divergence starting, the RSI is in the trader “buy zone” of the 50s, the wick on the candle is a bit longer than I would prefer, but with EXTO a wick that long just shows me that those that have been holding for a few months might have just taken some off the table.  Take a look at EXTO’s beautiful chart. http://stockcharts.com/h-sc/ui?s=EXTO&p=D&b=5&g=0&id=p01518581551

Support for EXTO comes in at .0075, with a lower level support of .006, and resistances lies ahead at .009, and .01.

Zoom technologies, inc. (Nasdaq: ZOOM) might be ready to go zoom, zoom, zoom and I will get to the techs after this REMINDER:

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to join the thousands of other roaches on Twitter for intraday plays, and for heads up tweets when things get  HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Zoom technologies, inc (Nasdaq: ZOOM) was my alert on Friday where there were plenty of shares at $1.30 – $1.32 and let me tell you my darlings that this puppy trades thin. 210K in volume ticks this sucker up a few pennies so I would like to see what it can do with some real volume. It appears that ZOOM will be tackling that $1.40 resistance sometime today. The techs from Friday are still in place.

Support for ZOOM comes in at $1.30 with a lower support level of $1.20, resistances lies ahead at $1.40, $1.50, and then it looks like it’s bluesky territory after $1.70.

For those that missed the ZOOM blog: http://www.stockroach.com/senorita-takes-a-look-at-zoom-technologies-inc-nasdaq-zoom-tech-updates-for-bpax-and-cbrx/

There’s a beautiful pincher on the MACD, and the buying volume is starting to get a bit heavier as well which is reflected in the RSI.

ZOOM chart: http://stockcharts.com/h-sc/ui?s=ZOOM&p=D&b=5&g=0&id=p71867454122

I’m really table pounding ZOOM guys and gals, and you know what happens when Senorita keeps pounding the table…..that’s right, the saavy roaches tend to rake it in while everyone ends up chasing  at a higher PPS or misses out completely haha.

Senorita “Rockin’ Wall St.” Roachita

Continue reading»

TGIF mi amors!

Today your Senorita is taking a look at a stock that is in such a sizzling hot sector that I give a 5 jalapeno salute to this spicy enchilada! I am talking about Zoom technologies, inc. (Nasdaq: ZOOM) a company that has subsidiaries which manufacture and distribute the latest in mobile hardware technology, and is also a major distributor for T-Mobile USA.

With offices worlwide, this aint no stinky pinky that’s for sure. With revenue projections upwards of $400 million this year, which would be a $100 million INCREASE over last year’s $300 million, this is one you want to put onto your watchlists immediately! This puppy trades like a low floater, and it has shown quite a few times in the past to move over $100% in a matter of days with a little bit of volume and interest.

For all things ZOOM check out their very informative website! http://www.zoom.com/

Support for ZOOM comes in at $1.30 with a lower support level of $1.20, resistances lies ahead at $1.40, $1.50, and then it looks like it’s bluesky territory after $1.70.

Zoom has had quite a bit of accumulation in the $1.20-$1.30 ranges, and it looks like it wants to bounce right off of the RSI 50.

I’ll get to the BPAX and CBRX techs right after this REMINDER:

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Let’s take a quick look at BioSante Pharmaceuticals (Nasdaq: BPAX) first and then I’ll get to CBRX. There’s been a lot of wondering about BPAX’s price and why it just can’t seem to stay over $1. Well with a rumored short count of 20 million or so, the bears are fighting back hard since they have more to lose. They are releasing their op-eds chock full of negativity and with bio-tech stocks being very news or should I say anal-yst sensitive it’s really no wonder that the price isn’t holding. My opinion is that the bears had a feeling that many would take profits upon the FDA giving the nod to Bio-T Gel and took advantage of the weakness in the share price as profit takers cashed out.

SAAVY ROACHES HAVE LOCKED IN BPAX GAINS UPWARDS OF 166% FROM MY ORIGINAL ALERT AT .45 SO FAR!

There has however been a strong accumulation of shares in the low to mid .80s, and it appears that the bulls will try and protect that .80 support region rather fiercly.

Support for BPAX comes in at .80, with a lower level support of .70. There was also a gap down in price, so their is a gap to be filled on the way up from .88 to $1.00.

Let’s finish this blog off with Columbia Laboratories (Nasdaq: CBRX) and just do a basic tech update on this FDA play with an NDA date from the FDA of Feb. 26th for their progesterone topical ointment Procheive, a joint venture with Watson Pharma (NYSE: WPI). So far CBRX IS UP 22% since MY ALERT AT .75!

Support for CBRX comes in at .80 with a lower level support at .75. Resistances lies ahead at .95, $1.00, and $1.10!

Check out my Valentine’s day blog for CBRX for more info on this fascinating bio-tech co.!

http://www.stockroach.com/its-fda-madness-biosante-pharmaceuticals-nasdaqbpax-and-columbia-laboratories-nasdaq-cbrx/

Senorita “It’s a Nasquack kinda day!” Roachita

Continue reading»

Teva Pharmaceutical Industries Ltd. (TEVA)and BioSante Pharmaceuticals Inc. (BPAX) won U.S. clearance to sell Bio-T-Gel, a testosterone replacement therapy for men.

The Food and Drug Administration approved the transdermal gel, the agency said today in an e-mail. Teva, of Petach Tikva, Israel, will market Bio-T-Gel for men with low testosterone. The condition, known as hypogonadism, can cause erectile dysfunction, infertility, osteoporosis and muscle loss, according to the Mayo Clinic in Rochester, Minnesota.

BioSante, the original developer of Bio-T-Gel, estimates the market for male testosterone products is more than $1.2 billion in the U.S., where hypogonadism affects as many as 5 million men. BioSante, of Lincolnshire, Illinois, licensed the gel to Teva, the world’s largest generic-drug maker, and will receive milestone payments and royalties when the drug is commercialized.

Abbott Laboratories (ABT) won FDA approval in April for a testosterone product known as AndroGel and later sued Teva, alleging that Bio-T-Gel infringed the product’s patent. Abbott, of Abbott Park, Illinois, and Teva settled the litigation in December without disclosing the terms, BioSante said Jan. 31 in a statement.

BioSante’s other experimental testosterone product, LibiGel, is a topical treatment applied to the arm for female sexual dysfunction. The company fell 77 percent, the most in 12 years, on Dec. 15 after the drug failed to work better than a placebo in two trials. BioSante said Jan. 31 that it would decide within 90 days whether to continue studying LibiGel.

To contact the reporter on this story: Molly Peterson in Washington at mpeterson9@bloomberg.net

To contact the editor responsible for this story: Adriel Bettelheim at abettelheim@bloomberg.net

Continue reading»

Good morning Roachland and Happy Valentine’s day!

I’m featuring 2 stocks today that have immediate FDA catalysts. Let’s kick this off with BioSante Pharmaceuticals (Nasdaq: BPAX) since today is the day that the FDA will show Bio-T Gel the love, or give them a, “Dear John” letter. In other words yay or nay to Bio-T Gel a transdermal testoserone treatment for male hypogonadism which is a $1.2 BILLION market in the U.S alone.

Male hypogonadism effects nearly 5 million men in the U.S. and can cause depression, hairloss, lowered sperm count, muscle loss and all sorts of problems that can even lead to infertility in the more severe cases.

So good luck to everyone that is holding shares of BioSante today! I am still in it to win it.

BioSante’s CEO Stephen M. Simes will be holding a conference and corporate update at 10:30am EST and the live feed can be found here: http://www.veracast.com/webcasts/bio/ceoinvestor2012/76206341.cfm

Should BPAX get the nod from the FDA today, the share price should in my roachy opinion go over $1 and stay there this time around. Should BPAX get denied approval or a delayed approval then we are most likely looking at .50-60 cents. This is only my opinion, and not definites on what will happen to the share price either way.

I’ll get to the next hot bio-tech after this brief REMINDER:

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Columbia Laboratories (Nasdaq: CBRX) was a twitter only alert last week on the 7th where it did a little pop for a few cents and then it was relentlessy walked down where a lot of traders started loading up in the mid .70s to low .80s. There’s a lot of accumulation in that price range and CBRX is holding above it’s support level of .70 with a lower support level coming in at .65. Resistance lies ahead at .85, .90 and $1.

CBRX did release news yesterday that they transferred the NDA for their progesterone 8% (Prochieve) to Watson Pharmeceuticals (NYSE: WPI) while maintaining full financial interest, and at no cost to Columbia labs. Procheive is a joint venture with Watson pharma that helps to prevent miscarriages in women and has shown a 44% reduction in early term births in women that used Prochieve under 33 weeks of gestation.

A 44% reduction is of course statistically significant, and for any woman that is at risk for early term births or miscarriages knows just how heartbreaking that can be and a product such as Prochieve is a Godsend. The FDA will review the NDA for Procheive by Feb. 26th so keep your eyes and ears open!

The news you may have missed courtesy of Yahoo finance: http://finance.yahoo.com/news/Columbia-Laboratories-prnews-1363429208.html?x=0

Senorita “All I want for Valentine’s is FDA approvals!” Roachita

Continue reading»

Happy Monday, Roachland!

Quamtel, Inc. (QUMI) built a nice little high-tech business selling wireless modems and data plans for laptop users on the go…nerds love it.

Traders, on the other hand, are more impressed at how QUMI’s efforts to kick up its business have pushed its chart into overdrive!

Check it out:

Those recent QUMI volume bars are NINE TIMES as tall as they were six short weeks ago, friend.

And massive turnover is leading massive price action. QUMI has printed a 2-digit candlestick every day so far this year.

The SMALLEST gave traders a 10% bottom-to-top payday, while the biggest…just a few days ago…was in sight of 50%

What’s gotten into the once-sedate QUMI, you ask?

The fun started at the gala Consumer Electronics Show in Las Vegas, where everyone in the world comes to show off their gadgets and QUMI’s “DataJack” was right at the center of things! (Read more)

After the show, QUMI really hit the ground running with full-page ads in in-flight magazines that maybe 180 MILLION
upscale travelers will read…and a fat distribution deal with multi-BILLION-dollar mobile broadband vendor ProutyCo.

Management thinks just that last deal should push QUMI above 100,000 subscribers and generate maybe $25 million in revenue this year alone.

Big plans, big headlines — and they’ve definitely generated momentum as the market races to re-rate how much to pay for QUMI shares!

The big-paycheck growth on the QUMI menu would be huge for a company that’s got only 23 million 50-cent shares on the table. (Read more)

Math quiz: if QUMI trades at 50 cents a share on maybe $2 million a year in sales, what will it be worth if it books those $25 million in new revenue…or even a fraction of them?

We rarely toss around terms like “multiple expansion” around here, but you have to admit that if QUMI can boost its business TEN TIMES over, the shares deserve at least a wee wiggle!

So go on, my roaches. Get your feelers on QUMI…before it’s out of reach for bottom feeders like us.

Papa Roach

Super Nova members raked in over 250K recently. Are you ready to bring home some of that
cash?

Continue reading»

Hola mi amors!

Happy Thursday, today I will be updating BioSante Pharmaceuticals (Nasdaq: BPAX)

BioSante Pharmaceuticals (Nasdaq: BPAX) has been driving Wall st. crazy with the volatility and those without the stomachs for it have been crying uncle. It all comes down to this mi amors,the closer a stock gets to a MAJOR catalyst such as PDUFA on Feb. 14th (which means if their Bio-T Gel gets PDUFA approved by the FDA it goes full commercial), the more people are going to try and shake you down for shares. This has definitely become a Balls of steel club stock, and only those with the big brass ones will win at this point. Many roaches have already raked in some massive gains from BPAX, but the balls of steel club roaches are going for MORE!

That my darlings is what is causing this volatility, it’s a share grab where hedgies, fundies, techies, traders, investors and everyone else under the sun is pulling out all stops (literally) to get as many shares of BPAX for as cheap as possible.

The ask is being walked down relentlessly, the bid is being pinged like crazy, BPAX has been on Nasquack’s forced short cover list for 2 days in a row which will also have an impact in the way it trades. The shorts want to cover for as much profits as possible, or they want to minimize losses since with  shorting those losses can be endless.

On a positive note, BPAX did release news today that the DMC report (Independant Data Monitoring Committee) for BPAX’s Libigel cardiovascular and breast health safety studies show signs of positive data and they have recommended that BPAX continue on with their Libigel tests without any further modifications. In laymen’s terms Libigel does not seem to cause any breast or heart problems.

Now they just need to work out that placebo trial thing out. Libigel is the holy grail of the medical world, since the dawn of time man has been looking for a magic potion that will make women more randy for sexy time and so far BPAX’s Libigel is the closest to making that happen.

The reason the placebo trial failed was due to the women on the placebo saying that they too felt just as randy as the women on the actual treatment. I want to get a look at the researcher that was handing out the placebo and monitoring the placebo group. It sounds to me like he was young and cute, especially in a labcoat haha.

Women! How do we work?

Today’s BPAX libigel news courtesy of Yahoo finance: http://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-885355718.html?x=0

I’ll get to your techs after this brief reminder, especially since Papi Roachy has a mega hot alert on deck for tomorrow!

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Support for BPAX comes in at .80, and resistance lies ahead at .95 and $1.

Senorita “Balls of steel club member” Roachita

Continue reading»

Hola Roacheros!

Atrinsic, inc. (Pink: ATRN) is our first “almost” 10 bagger of the year!  Are you really going to give me crap over a few ticks when the stock ran from my original alert on Jan. 4th at a PPS of .013, where it hit an amazing early HOD today of .135 for some ASS KICKING, MOUTH WATERING, HOLY GUACAMOLE gains upwards of 938% in a month?

There were also updates after updates on this roachy gem, just go to the search bar and you will see that we nailed ATRN each and every time! Here’s a link for everytime ATRN was updated: http://www.stockroach.com/?s=atrn

Chalk another one up for the StockRoach, nail it to the bedpost and tell the story to your grandchildren current or future!, The best part is that this is only the beginning mi amors, between Papa Roach and I, we will be bringing you some of the hottest stocks, the biggest pumps, and $$$ flowing into your accounts to the point where even Las Vegas will want some peanut butter with their JELLY (jealous) by the time this fiscal year ends.

Want some more HOT alerts before the chaff comes sniffing around for our scraps?

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Senorita “BOOYAH and a bucket full of cash!” Roachita

Continue reading»

Happy Tuesday mi amors.

I’ll make this a quickie, I have my eyes on THQ, Inc. (Nasdaq: THQI) as a chart play. It’s been accumulating very nicely after it’s TIMBERRRRRRRRRR from .70 to the low .50s on disappointing financials, but it has set a double bottom at .55 and is now starting to bounce like a jumping bean from those levels. With a close twards the high of day, and buying volume just starting to hit, I personally wouldn’t take my eyes off of this puppy.

How many stocks have we seen take off from these lelvels to over $1 recently? Plenty my darlings, plenty haha.

THIQ is a worldwide developer and publisher of interactive entertainment software aka VIDEO GAMES for all home gaming systems such as the Xbox 360, Nintendo Wii, Sony PlayStation 3 (PS3), Sony PlayStation 2 (PS2), handheld gaming devices like the Nintendo DSi, Playstation PSP, and all manners of wireless devices….Smartphones, tablets, iPads, and even games for online multiplayer through home PCs.

For everything THQ, Inc. Check out their informative website readable in 7 different languages! http://www.thq.com/go/language/select?origin_url=aHR0cDovL3d3dy50aHEuY29tLw..&skip_lang_redirect=1

I’ll get to your techs after this brief reminder for all you FREELOADING LURKERS!

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

The chart for THQI is set up beautifully imo for a very nice retrace. Current support comes in at .60 tentatively with a lower level support range at .55. Resistance lies ahead at .65 and .72.

The accumulation is starting to rose, the MACD is starting to pinch, and the RSI is starting to show buying pressure.

Chart courtesy of Stockcharts.com: http://stockcharts.com/h-sc/ui?s=THQI&p=D&b=5&g=0&id=p83341282730

Senorita “Let’s play!” Roachita

Continue reading»

Just a quick BPAX update for mi amors.

Shares of BioSante (Nasdaq: BPAX) goes wilder than a drunken frat boy on spring break.

With their highly anticipated Feb. 14th date where their Bio-T Gel a transdermal testosterone booster for men with low test. levels goes up against the FDA for full approval it’s no surprise that BPAX is a stock that has Wall St. screaming it’s praises!

So it’s time for a quick technical update on Senorita’s favorite bio-tech trading that is now trading at $1.05 that has brought gains upwards of 133% since my original alert at .45.

Support comes in at $1.00 with a lower level support at .92, and the new resistances lies ahead at $1.12 and $1.20 on the daily charts. Should $1.20 break and hold then the next level of resistance is $1.50.

Chart courtesy of stockcharts.com: http://stockcharts.com/h-sc/ui?s=BPAX&p=D&b=5&g=0&id=p24951525252

Papa Roach has a muy caliente alert heading your way tomorrow morning at the bell, and I have a nice tech trade bottom bouncer coming out pre-market.

So what are you waiting for?

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Senorita “Never fall in love with a stock unless it is BPAX haha” Roachita.

Continue reading»

Just a quick roundup on my 5 for 5 blog from this morning.

Link if you missed the pre-market 5 for 5. http://www.stockroach.com/tgif-its-senoritas-hot-stock-roundup-mnel-atrn-bpax-motr-and-mvis/

Atrinsic, inc. (Pink: ATRN) brings yet another round of wins if you were late to the party. It gapped down at open allowing for some very nice cheaps in the .055 range and hit an intraday high of  .085 for some fast track gains upwards of 54.5 %. I would still keep my eyes peeled on this puppy because the money is flowing nicely, and it appears to be consolidating at higher levels.

Mission NewEnergy (Nasdaq: NMEL) gapped up nicely at open today to hit a high of $1.25 from yesterday’s alert price of .83 for an overnight quickie that brought in gains upwards of 50% for very saavy roaches. Unfortunately this one turned into a stinker midday and some dilution might be occuring because it broke supports on heavy volume and just was not trading in a very healthy manner. This is why we always lock in those gains darlings!

BioSante Pharmaceuticals (Nasdaq: BPAX) finally broke it’s 1st major resistance at .70 and closes up 8% over the previous day at a very respectable power hour last second push at .74 , and with their FDA catalyst coming soon aren’t you glad I let you all know about BPAX when it was all you could buy .45s? I’m sure they look cheaper than anything on the McDonald’s $1 menu right about now haha. Even those of you that bought the .60s are starting to sound less morose. Lot less crying and much more buying going on at BPAX. Good times, and dollarland… you can almost smell it from here.

Microvison, inc. (Nasdaq: MVIS) my little chart play opened nicely with all you could grab .42s-.43s where it took off running to hit a high of .5198 for nice 24% snipe trade.

Let’s finish this roundup with this week’s El SUPERBEASTO Motricity, inc. (Nasdaq: MOTR) that was alerted when shares were abundant at .77 last week, and it is dazzling Wall St. with a mega 2 day rally that sent shares soaring to an intraday high of $1.29 for HOLY GUACAMOLE gains upwards of 67.5%!

Papa Roach’s rocking alerts have also brought in cumulative gains well into the triple digits this month as well, and he has another hottie on deck for Monday. Teasers will be sent out via e-mail over the weekend so:

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get interesting HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Senorita “This is easier than taking candy from a baby!” Roachita!

Continue reading»